4-chloro-3-methoxyphenylboronic acid
Product Information
Molecular Formula
C7H8BClO3
Molecular Weight
186.40
Description
4-chloro-3-methoxyphenylboronic acid is a vital compound widely used in biomedicine. It is utilized to develop therapeutic drugs to treat various diseases, mainly targeting cancer, inflammation, and autoimmune disorders.
Synonyms
(4-chloro-3-methoxyphenyl)boronic acid; Boronic acid, (4-chloro-3-methoxyphenyl)-; 4-chloro-3-methoxybenzeneboronic acid; 4-Choro-3-methoxyphenylboronic acid; 4-chloro-5-methoxyphenylboronic acid; 4-chloro-3-methoxy phenylboronic acid; 4-chloro-3-methoxyphenyl boronic acid; 4-chloro-3-methoxyphenylboronic acid; 4-Chloro-3-methoxyphenylboronic Acid (contains varying amounts of Anhydride); (4-chloro-3-methoxy-phenyl)boronic acid; 4-Chloro-3-methoxyphenylboronic acid
IUPAC Name
(4-chloro-3-methoxyphenyl)boronic acid
SMILES
B(C1=CC(=C(C=C1)Cl)OC)(O)O
InChI
InChI=1S/C7H8BClO3/c1-12-7-4-5(8(10)11)2-3-6(7)9/h2-4,10-11H,1H3
InChI Key
DZNNRXURZJLARZ-UHFFFAOYSA-N
Flash Point
Not applicable
Computed Properties
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
3
Rotatable Bond Count
2
Exact Mass
186.0255020 g/mol
Monoisotopic Mass
186.0255020 g/mol
Topological Polar Surface Area
49.7Ų
Heavy Atom Count
12
Formal Charge
0
Complexity
145
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2022034046-A1 | Metal complexes | 2020-08-13 |
| WO-2021130732-A1 | Antibacterial quinolines | 2019-12-27 |
| CN-112574189-A | EP300/CBP inhibitor | 2019-09-27 |
| WO-2021057915-A1 | Ep300/cbp inhibitor | 2019-09-27 |
| WO-2020257487-A1 | Glycolate oxidase inhibitors for the treatment of disease | 2019-06-19 |
| TW-202115013-A | Glycolate oxidase inhibitors for the treatment of disease | 2019-06-19 |
| CA-3143334-A1 | Glycolate oxidase inhibitors for the treatment of disease | 2019-06-19 |
| CN-109536182-A | Liquid-crystal compounds, liquid crystal media and application | 2018-12-19 |
| CN-109536182-B | Liquid crystal compound, liquid crystal medium and application | 2018-12-19 |
| WO-2019234405-A1 | Compounds useful in the treatment of disorders associated with mutant ras | 2018-06-04 |
